What's in Store for Boston Scientific (BSX) in Q3 Earnings?

With global staffing issues and the supply situation gradually improving, Boston Scientific's (BSX) international business is expected to have improved further in the third quarter.

Related Keywords

Japan ,China ,Boston ,Massachusetts ,United States ,Asia Pacific ,Apollo Endosurgery ,Wavewriter Alpha ,Prostate Health ,Zacks Investment Research ,Access Solutions ,Boston Scientific ,Pelvic Health ,Ligand Pharmaceuticals ,Urology Pelvic Health ,Boston Scientific Corporation ,World Medical Device ,Interventional Cardiology ,Coronary Therapie ,Heart Valves ,Peripheral Interventions ,Packing Coils ,Spinal Cord Stimulation ,Vercise Genus ,Zacks Consensus Estimate ,Zacks Rank ,Strong Buy ,Ligand Pharmaceutical ,Spero Therapeutic ,Inspire Medical ,Zacks Earnings ,Zacks Investment ,Revenue Growth ,Reported Quarter ,